Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
852,412
Value
$47.8M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RPRX by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026852,412$47.8M<0.1%+66,017+8.4%AddedHolders
Q1 2026786,395$37.7M<0.1%−59,150−7.0%ReducedHolders
Q4 2025845,545$32.7M<0.1%+61,939+7.9%AddedHolders
Q3 2025783,606$27.6M<0.1%−320,438−29.0%ReducedHolders
Q2 20251,104,044$39.8M<0.1%−495,192−31.0%ReducedHolders
Q1 20251,599,236$49.8M<0.1%+800,728+100.3%AddedHolders
Q4 2024798,508$20.4M<0.1%−157,472−16.5%ReducedHolders
Q3 2024955,980$27.0M<0.1%+51,544+5.7%AddedHolders
Q2 2024904,436$23.8M<0.1%+879,632+3,546.3%AddedHolders
Q1 202424,804$753.3K<0.1%−161,392−86.7%ReducedHolders
Q4 2023186,196$5.23M<0.1%+171,249+1,145.7%AddedHolders
Q3 202314,947$405.7K<0.1%+14,947NewHolders
Q2 20230$00.0%−10,462−100.0%Sold outHolders
Q1 202310,462$376.9K<0.1%−118,157−91.9%ReducedHolders
Q4 2022128,619$5.08M<0.1%−18,751−12.7%ReducedHolders
Q3 2022147,370$5.92M<0.1%−164,748−52.8%ReducedHolders
Q2 2022312,118$13.1M<0.1%+2,236+0.7%AddedHolders
Q1 2022309,882$12.1M<0.1%−182,912−37.1%ReducedHolders
Q4 2021492,794$19.6M<0.1%+37,900+8.3%AddedHolders
Q3 2021454,894$16.4M<0.1%−32,128−6.6%ReducedHolders
Q2 2021487,022$20.0M<0.1%−52,884−9.8%ReducedHolders
Q1 2021539,906$23.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.